this team developed a method using single-cell screening to test very large numbers of human plasma cells, to increase their odds of finding an antibody even if it was extremely rare. when they identified fi6, they injected it into mice and ferrets and found that it protected the animals against infection by either a group 1 or group 2 influenza a virus.